coal imports Archives

Here are some of the major updates that could move the markets tomorrow:

Asian Paints Q2 Results: Net profit rises 31% YoY to ₹783 crore

Asian Paints Ltd reported a 31.3% YoY increase in consolidated net profit to ₹782.71 crore for the quarter ended Sept (Q2 FY23). Its revenue from operations rose 19% YoY to ₹8,457.6 crore during the same period. EBITDA stood at ₹1,227.7 crore in Q2, up 36% YoY. The company’s board has approved an interim dividend of ₹4.4 per share.

Asian Paints will invest ₹2,100 crore to set up a facility to manufacture Vinyl Acetate Ethylene Emulsion (VAE) and Vinyl Acetate Monomer (VAM). VAE is a key constituent to manufacturing environmentally friendly paints, and VAM is a key input to making VAE.

Read more here.

Coal import to be stopped by 2024: Pralhad Joshi

Union Coal Minister Pralhad Joshi said the import of coal, which has declined considerably, will be stopped by 2024. The minister said commercial coal mine auction, which was institutionalised by the present government, has made the auctioning process totally transparent. According to Joshi, coal production in the current financial year (FY23) is expected to touch 900 million tonnes.

Read more here.

Axis Bank Q2 Results: Net profit rises 70% YoY to ₹5,330 crore

Axis Bank reported a 70% YoY (or 29% QoQ) increase in net profit to ₹5,330 crore for the quarter ended Sept (Q2 FY23). The net interest income (NII) grew 31% YoY to ₹10,360 crore during the same period. The gross non-performing assets ratio (GNPA) improved to 2.5% in Q2, compared to 2.76% in Q1. Provisions fell 68% YoY to ₹549.78 crore in Q2 FY23.

Read more here.

Bajaj Finance Q2 Results: Net profit rises 88% YoY to ₹2,781 crore

Bajaj Finance reported an 88% YoY increase in net profit to ₹2,781 crore for the quarter ended Sept (Q2 FY23). Its net interest income (NII) rose 31% YoY to ₹7,001 crore during the same period. The assets under management (AUM) stood at ₹2,18,366 crore in Q2, up 31% YoY. The gross non-performing assets ratio (GNPA) improved to 1.17% in Q2, compared to 2.45% in Q1.

Read more here.

SEBI clears govt proposal to turn Vodafone Idea dues into equity: Report

As per a Reuters report, the Securities & Exchange Board of India (SEBI) has approved the government’s proposal to convert Vodafone Idea’s dues of over $1.92 billion to equity. Last year, the central government approved a rescue package for debt-strapped telecom companies that allowed them to convert interest on deferred adjusted gross revenues (AGRs) owed to the government into equity.

Vi’s board is scheduled to meet on October 21 to consider the issuance of debentures convertible into equity shares on a preferential basis to a vendor.

Read more here.

Tata Consumer Q2 Results: Net profit rises 22% YoY to ₹328 crore

Tata Consumer Products Ltd reported a 22% YoY increase in net profit to ₹327.9 crore for the quarter ended Sept (Q2 FY23). Its revenue from operations rose 11% YoY to ₹3,363.1 crore during the same period. The FMCG company’s expenses stood at ₹3,021.9 crore in Q2, up12% YoY. Revenue from its India business grew 9.2% YoY to ₹2,159.9 crore.

Read more here.

Adani Transmissions secures ₹1,300 crore deal from Mumbai’s BEST

Adani Transmission Ltd has secured a deal worth ₹1,300 crore to install and maintain 10.80 lakh smart meters for BEST Undertaking. The Brihanmumbai Electric Supply and Transport (BEST) Undertaking is a state-run utility that serves consumers in the island city exclusively. The current contract involves installing the smart meters over 30 months and maintaining them for the following 90 months.

Read more here.

Dixon Tech Q2 Results: Net profit rises 23% YoY to ₹77 crore

Dixon Technologies Ltd reported a 23.11% YoY increase in consolidated net profit to ₹77.12 crore for the quarter ended Sept (Q2 FY23). Its revenue from operations rose 37.91% YoY to ₹3,866.77 crore during the same period. Total expenses stood at ₹3,766.54 crore in Q2, up 38.24% YoY. Revenue from its consumer electronics business stood at ₹1,500.7 crore, while revenue from lighting products stood at ₹290.4 crore.

Read more here.

Glenmark Pharma launches drug for diabetic patients with comorbidities

Glenmark Pharmaceuticals Ltd has launched a fixed-dose combination for the treatment of diabetes for patients with comorbidities (more than one disease or medical condition). The Mumbai-based drug maker has become the first company to launch Teneligliptin (20mg) + Dapagliflozin (5mg/10mg) fixed-dose combination to treat Type-2 diabetes in adult patients. The new drug is marketed under the Zita D brand.

Read more here.

IEX Q2 Results: Net profit falls 7% YoY to ₹71 crore

Indian Energy Exchange (IEX) reported a 7% YoY decline in consolidated net profit to ₹71 crore for the quarter ended Sept (Q2 FY23). Its revenue from operations fell 13% YoY to ₹95 crore during the same period. EBITDA stood at ₹78.9 crore in Q2, down 17% YoY.

Here are some of the major updates that could move the markets on Monday:

Equity mutual fund inflows hit 10-month low in August

Data released by the Association of Mutual Funds in India (AMFI) showed that Inflows into equity mutual funds fell 31% YoY to ₹6,119.58 crore in August. Investors continued to withdraw money amidst rising interest rates and high inflation. The monthly Systematic Investment Plan (SIP) contribution stood at ₹12,693.45 crore in August, an all-time high.

The mutual fund industry’s net assets under management (AUM) hit an all-time high of ₹39.33 lakh crore in August, increasing 7% YoY.

Read more here.

Govt clears PLI incentive of ₹53 crore for Dixon Tech

Dixon Technologies Ltd has become the first producer of mobile phones to get approval for the disbursement of incentives under the government’s Production-Linked Incentive (PLI) scheme. The company will be eligible to receive ~₹53 crore for the first quarter of operation between October to December 2021 as an incentive on incremental sales. The incentive amount will be disbursed in the next few days.

Read more here.

India considers new coal imports as energy supply concern grows

Energy officials in India are considering whether further coal imports may be needed to avoid any power supply crunch. Stockpiles of coal at power plants have fallen about 11% since mid-August, meaning utilities have an average of 10 days’ supply. This is well below the required levels of more than three weeks. Coal helps produce about 70% of India’s electricity.

Read more here.

PVR to seek approval from shareholders, creditors on Oct 11 for merger with INOX

PVR has called a meeting of its shareholders and creditors on October 11 to seek their approval for its merger with INOX Leisure. The two entities announced the merger plan in March 2022, and the merged company will be called PVR Inox. However, the branding of existing screens will continue as PVR and INOX. The boards of both companies decided that the shareholders of INOX Leisure would receive 3 stocks of PVR for every 10 stocks of Inox they hold.

Read more here.

Zydus Lifesciences secures rights to market MonoFerric injection in India, Nepal

Zydus Lifesciences Ltd has secured rights to market MonoFerric injection in India and Nepal from Denmark-based Pharmacosmos A/S. The drug is used to treat iron deficiency in adult patients when oral iron preparations are ineffective. MonoFerric is available in over 30 countries (including the US and Europe), and over 28 million doses have been administered since launch.

Read more here.

Tata Group in talks to join an elite club of iPhone makers

Tata Group is in talks with Wistron Corp, a Taiwanese supplier to Apple Inc., to establish an electronics manufacturing joint venture as they seek to assemble iPhones in India. As per reports, Tata Group wants to tap Wistron Corp’s expertise in product development, supply chain, and assembly. If successful, the pact could make Tata the first Indian company to build iPhones.

Read more here.

Lupin gets USFDA approval for generic used to cleanse colon

Lupin Ltd has launched the generic version of Suprep Bowel Prep Kit Oral Solution in the US after getting approval from the US Food & Drug Administration (USFDA). The drug is used for cleansing the colon as a preparation for colonoscopy. As per IQVIA MAT data, RLD Suprep Bowel Prep Kit had estimated sales of $202 million in the U.S during the 12 months ended July 2022.

Read more here.

Ashok Leyland signs pact with UK-based Libertine for powertrain technology

Ashok Leyland Ltd has signed an agreement with UK-based Libertine Holdings to evaluate the use of Libertine’s technology platform for its commercial vehicle (CV) powertrains. Libertine is a developer of clean and fuel-flexible linear generator technology (LGT). Under the terms of the agreement, Ashok Leyland will explore the scope for LGT product development and demonstration within its CV portfolio.

Read more here.

PI Industries looks to buy promoter stake in Granules India: Report

As per a report by ET NOW, PI Industries is looking to acquire a promoter stake in Granules India. “Initial discussions between the two companies have already taken place,” the report said. The promoters of Granules India have a 42% stake in the pharma company valued at ₹3,200 crore.

Read more here.